Jin Sook
Jin Sook Ahn, Suwon-Si KR
| Patent application number | Description | Published |
|---|---|---|
| 20100110310 | MOBILE TERMINAL HAVING PROJECTOR AND METHOD OF CONTROLLING DISPLAY UNIT IN THE MOBILE TERMINAL - A mobile terminal having a projector and a method for controlling a display unit in of the mobile terminal are provided. The method includes outputting, if a presentation application is selected, a screen image for performing the selected presentation application through the display unit and the projector, turning off power supplied to an entire area of the display unit, and performing, if a touch is detected through the touch screen, a function according to the detected touch in the selected presentation application. | 05-06-2010 |
Jin Sook Bang, Ansan-Si KR
| Patent application number | Description | Published |
|---|---|---|
| 20150029692 | OPTICAL LENS MODULE AND BACKLIGHT UNIT - A backlight unit which provides light to a liquid crystal display panel of a liquid crystal display. The backlight unit includes an optical lens module including an optical lens disposed above a point light source and configured to refract light output from the point light source, and a reflective polarization layer disposed directly on the optical lens and configured to separate polarization components of the light to transmit one polarization component and reflect another polarization component. | 01-29-2015 |
Jin Sook Kim, Uiwang-Si KR
| Patent application number | Description | Published |
|---|---|---|
| 20120170117 | POLARIZER PLATE, OPTICAL APPARATUS, AND METHOD OF MANUFACTURING POLARIZER PLATE - A polarizer plate includes a polarizer that includes polyvinyl alcohol and a dichroic material, the polarizer having a degree of orientation of 15 or more as represented by Equation 1: Degree of orientation=R | 07-05-2012 |
| 20130114137 | POLARIZER HAVING ENHANCED PHOTODURABILITY AND METHOD FOR PREPARING THE SAME - A polarizer includes boric acid, potassium iodide, and a zinc salt. The zinc salt has a concentration gradient in which the concentration of the zinc salt gradually decreases from a surface of the polarizer to an interior thereof | 05-09-2013 |
| 20130163081 | POLARIZING PLATE FOR ORGANIC LIGHT-EMITTING DISPLAY AND DISPLAY DEVICE INCLUDING THE SAME - A polarizing plate for use with an organic light emitting display includes an adhesive layer, a retardation film, a polarizer, and a protective film sequentially stacked in this order, the polarizing plate further including a positive C plate. | 06-27-2013 |
Jin Sook Kim, Gwangju KR
| Patent application number | Description | Published |
|---|---|---|
| 20100099144 | COMBINED USE OF CELL PERMEABLE NANOG AND OCT4 FOR INCREASING SELF-RENEWAL AND SUPPRESSING DIFFERENTIATION OF STEM CELLS - The present invention discloses cell permeable Nanog and Oct4 recombinant proteins that comprise a kaposi fibroblast growth factor 4 (kFGF4)-derived macromolecule transduction domain (MTD). Also disclosed are polynucleotides encoding the cell permeable Nanog and Oct4 recombinant proteins, a method of increasing self-renewal and suppressing differentiation of stem cells by treating the cells in combination with the cell permeable Nanog and Oct4 recombinant proteins, and the combined use of the cell permeable Nanog and Oct4 recombinant proteins for increasing self-renewal and suppressing differentiation of stem cells. | 04-22-2010 |
| 20100197598 | NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - The present invention discloses novel macromolecule transduction domain (MTD) peptides which facilitate the traverse of a biologically active molecule across the cell membrane. Also disclosed are polynucleotides encoding the MTD peptides, methods of identifying the MTD peptides; methods of genetically engineering a biologically active molecule to have cell permeability by using the MTD peptides, methods of importing a biologically active molecule into a cell by using the MTD peptides, and uses thereof. | 08-05-2010 |
| 20140186379 | NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - The present invention discloses novel macromolecule transduction domain (MTD) peptides which facilitate the traverse of a biologically active molecule across the cell membrane. Also disclosed are polynucleotides encoding the MTD peptides, methods of identifying the MTD peptides; methods of genetically engineering a biologically active molecule to have cell permeability by using the MTD peptides, methods of importing a biologically active molecule into a cell by using the MTD peptides, and uses thereof. | 07-03-2014 |
Jin Sook Kim, Seoul KR
| Patent application number | Description | Published |
|---|---|---|
| 20090087504 | METHOD FOR TREATING DIABETIC COMPLICATIONS - The present invention relates to a method for treating diabetic complications, which comprises administering an extract obtained by: crashing and drying any one selected from Euphorbiae radix, gingered | 04-02-2009 |
| 20120100233 | COMPOSITIONS FOR TREATMENT AND PREVENTION OF DIABETIC COMPLICATIONS USING OSTEOMELES SCHWERINAE - The present invention relates to a treatment agent for diabetic complications, and a method for the treatment of diabetic complications using the same. The present invention confirmed that | 04-26-2012 |
| 20120183633 | COMPOSITIONS AND FUNCTIONAL FOODS FOR TREATING AND PREVENTING OBESITY USING POLYGONUM CUSPIDATUM BUTANOL FRACTION AND ETHYL ACETATE FRACTION - The present invention relates to the obesity-curative or obesity-preventive effect of a | 07-19-2012 |
| 20130316030 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING COMPLICATIONS OF DIABETES CONTAINING A TRADITIONAL ORIENTAL MEDICINE EXTRACT OR A FRACTION THEREOF AS AN ACTIVE INGREDIENT - The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetic complications comprising the extract of | 11-28-2013 |
Jin Sook Kim, Gwanak-Gu KR
| Patent application number | Description | Published |
|---|---|---|
| 20130210928 | NOVEL BIPHENYL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARING NOVEL BIPHENYL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DIABETES COMPLICATIONS - The present invention provides a novel biphenyl compound or pharmaceutically acceptable salts thereof, methods for preparing the same, and pharmaceutical compositions for preventing or treating diabetic complications containing the same as an active ingredient. Novel biphenyl compounds, according to the present invention, effectively suppress generation activity of advanced glycation end products, which cause diabetic complications and are a criterion for evaluating the effectiveness of a treating agent for diabetic complications, and show an excellent therapeutic effect on retina blood vessels, increased occludin, and decreased angiogenic growth factor in actual diabetic retinopathy induced retina. Thus, novel biphenyl compounds according to the present invention can be used effectively as an active ingredient in compositions for preventing or treating diabetic complications such as diabetic retinopathy. | 08-15-2013 |
Jin Sook Kwon, Gwangju KR
| Patent application number | Description | Published |
|---|---|---|
| 20140018908 | Gene Delivery Stent Using Titanium Oxide Thin Film Coating, and Method for Fabricating Same - The present invention relates to a gene delivery stent using titanium oxide thin film coating and a method for fabricating the gene delivery stent. The gene delivery stent according to the present invention may be loaded with a drug having anti-inflammatory and anti-thrombotic effects and simultaneously deliver a gene capable of inhibiting proliferation of vascular smooth muscle cells. Accordingly, late thrombosis and metal allergy may be reduced, and vascular restenosis in the stent region may be prevented, thereby making it possible to increase treatment effects of the bare metal stent. | 01-16-2014 |
Jin Sook Lee, Daejeon KR
| Patent application number | Description | Published |
|---|---|---|
| 20150315277 | DUAL-TARGET ANTIBODY TARGETING VEGFR-2 AND DLL4, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME - The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody. | 11-05-2015 |
Jin Sook Ryu, Daejeon KR
| Patent application number | Description | Published |
|---|---|---|
| 20140214338 | POLYMER SIDE CHAIN ANALYSIS METHOD AND POLYMER SIDE CHAIN ANALYSIS DEVICE - The present disclosure relates to an apparatus and a method for analyzing side chains of a polymer. More specifically, the present disclosure relates to an apparatus and a method for analyzing the number of side chains of a polymer. | 07-31-2014 |
Jin Sook Song, Daejeon KR
| Patent application number | Description | Published |
|---|---|---|
| 20100105704 | 7-(3',4'-Dialkoxyphenyl)-[1,2,4]-Triazolo[1,5-A]Pyrimidine Compounds, Process for Preparing Thereof, and Pharmaceutical Composition for Treating or Preventing Asthma, Chronic Obstructive Pulmonary Disease, Arthritis, Atopic Dermatitis, Tumor and Degenerative Brain Diseases Comprising the Same - The present invention relates to novel {7-(3′,4′-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compounds or pharmaceutically acceptable salts thereof, a process for preparing the same, and pharmaceutical compositions for treating or preventing inflammatory diseases including asthma and chronic obstructive pulmonary disease, arthritis, atopic dermatitis, cancers including leukemia, and degenerative brain diseases including Alzheimer's disease, depression and memory impairment, which comprises the same as an active ingredient. | 04-29-2010 |
Jin Sook Yoon, Suwon-Si KR
| Patent application number | Description | Published |
|---|---|---|
| 20090144650 | MULTIMEDIA APPARATUS TO SUPPORT MULTIPLE LANGUAGES AND METHOD FOR PROVIDING MULTILINGUAL USER INTERFACE FOR THE SAME - A multimedia apparatus and a user interface (UI) for multiple languages. The multimedia apparatus determines a function of an input user command according to a direction in which a set language is written, so users can use a multimedia apparatus supporting multiple languages more naturally. | 06-04-2009 |
| 20110047510 | MOBILE TERMINAL AND SCREEN COMPOSITION METHOD FOR THE SAME - A mobile terminal and screen composition method for the same are provided. The screen composition method may compose distinct screens having different icons and arrangements according to various collected information in relation to time, location and others, and output a screen that is adapted to the current situation. Hence, the user may use the mobile terminal in an easy and convenient manner. | 02-24-2011 |
Jin-Sook Chang, Seoul KR
| Patent application number | Description | Published |
|---|---|---|
| 20090253186 | MICROORGANISM PRODUCING L-METHIONINE PRECURSOR AND THE METHOD OF PRODUCING L-METHIONINE PRECURSOR USING THE MICROORGANISM - The present invention relates to a microorganism producing L-methionine precursor, O-acetylhomoserine, and a method of producing L-methionine precursor using the microorganism. | 10-08-2009 |
| 20090253187 | MICROORGANISM PRODUCING L-METHIONINE PRECURSOR AND THE METHOD OF PRODUCING L-METHIONINE PRECURSOR USING THE MICROORGANISM - The present invention relates to a microorganism producing L-methionine precursor, O-succinylhomoserine, and a method of producing L-methionine precursor using the microorganism, | 10-08-2009 |
| 20090325243 | Method for producing amino acids using glycerol - The present invention relates to an amino acid-producing microorganism capable of simultaneously utilizing glycerol as a carbon source, a method for preparing the microorganism, and a method for producing amino acids using the microorganism. According to the present invention, amino acids can be efficiently produced using a byproduct of biodiesel production, glycerol, thereby substituting a cheaper material for the conventional fermentation materials such as glucose. | 12-31-2009 |
| 20100184164 | Microorganism Producing L-Methionine Precursor And Method Of Producing L-Methionine And Organic Acid From The L-Methionine Precursor - The present invention relates to a method for producing L-methionine and organic acid comprising the following steps: Step 1) preparing a strain producing L-methionine precursor and producing L-methionine precursor by the fermentation of the strain; Step 2) producing L-methionine and organic acid by the enzyme reaction process with the L-methionine precursor as a substrate, and microorganism strains used in each step. | 07-22-2010 |
| 20110183383 | Compositions and Methods of Producing Methionine - Described herein are microorganisms that produce methionine and related products from endogenous genes in a transsulfuration pathway, as well as from exogenous genes providing a direct sulfhydrylation pathway. Novel genes that are useful for methionine and SAMe production are disclosed. | 07-28-2011 |
| 20110207184 | MICROORGANISM PRODUCING L-METHIONINE PRECURSOR AND THE METHOD OF PRODUCING L-METHIONINE PRECURSOR USING THE MICROORGANISM - The present invention relates to a microorganism producing L-methionine precursor, O-acetylhomoserine, and a method of producing L-methionine precursor using the microorganism. | 08-25-2011 |
| 20120190080 | O-PHOSPHOSERINE SULFHYDRYLASE MUTANTS AND METHOD FOR PRODUCTION OF CYSTEINE USING THE SAME - Disclosed is an O-phosphoserine sulfhydrylase (OPSS) mutant which has a | 07-26-2012 |
| 20120190081 | MICROORGANISM PRODUCING O-PHOSPHOSERINE AND METHOD OF PRODUCING L-CYSTEINE OR DERIVATIVES THEREOF FROM O-PHOSPHOSERINE USING THE SAME - The present invention provides methods for the production of cysteine or derivates thereof by culturing a microorganism having reduced activity of endogenous phosphoserine phosphatase. The O-phosphoserine produced by such an organism can then be reacted with a sulfide in the presence of a sulfydrylase or a microorganism expressing a sulfhydrylase to produce cysteine or a derivative thereof. Microorganisms having the properties noted above are also provided herein. | 07-26-2012 |
| 20120190082 | MICROORGANISM PRODUCING O-PHOSPHOSERINE AND METHOD OF PRODUCING L-CYSTEINE OR DERIVATIVES THEREOF FROM O-PHOSPHOSERINE USING THE SAME - The present invention provides methods for the production of cysteine or derivates thereof by culturing a microorganism having reduced activity of endogenous phosphoserine phosphatase and enhanced activity of phosphoglycerate dehydrogenase and/or phosphoserine aminotransferase. The O-phosphoserine produced by such an organism can then be reacted with a sulfide in the presence of a sulfydrylase or a microorganism expressing a sulfhydrylase to produce cysteine or a derivative thereof. Microorganisms having the properties noted above are also provided herein. | 07-26-2012 |
| 20120190083 | MICROORGANISM PRODUCING O-PHOSPHOSERINE AND METHOD OF PRODUCING L-CYSTEINE OR DERIVATIVES THEREOF FROM O-PHOSPHOSERINE USING THE SAME - The present invention provides methods for the production of cysteine or derivates thereof by culturing a microorganism having reduced activity of endogenous phosphoserine phosphatase and the activity of PhnC, PhnD, and PhnE is reduced, and enhanced activity of phosphoglycerate dehydrogenase and/or phosphoserine aminotransferase. The O-phosphoserine produced by such an organism can then be reacted with a sulfide in the presence of a sulfydrylase or a microorganism expressing a sulfhydrylase to produce cysteine or a derivative thereof. Microorganisms having these reduced and enhanced properties noted above are also provided herein. | 07-26-2012 |
| 20130231503 | Microorganism producing L-methionine precursor and method of producing L-methionine and organic acid from the L-methionine precursor - The present invention relates to a method for producing L-methionine, comprising: i) culturing an L-methionine precursor-producing microorganism strain in a fermentation solution, so that the L-methionine precursor accumulates in the solution; and ii) mixing a converting enzyme and methylmercaptan or its salts with at least a portion of the solution to convert the accumulated L-methionine precursor into L-methionine, as well as to microorganism strains used in each step. | 09-05-2013 |
| 20130260424 | Compositions and Methods of Producing Methionine - Described herein are microorganisms that produce methionine and related products from endogenous genes in a transsulfuration pathway, as well as from exogenous genes providing a direct sulfhydrylation pathway. Novel genes that are useful for methionine and SAMe production are disclosed. | 10-03-2013 |
| 20140296466 | Method for Producing Bio-Based Homoserine Lactone and Bio-Based Organic Acid from O-Acyl Homoserine Produced by Microorganisms - The present invention relates to a method of producing bio-based homoserine lactone and bio-based organic acid through hydrolysis of O-acyl homoserine produced by a microorganism in the presence of an acid catalyst. According to the present invention, O-acyl homoserine produced by a microorganism is used as a raw material for producing 1,4-butanediol, gamma-butyrolactone, tetrahydrofuran and the like, which are industrially highly useful. The O-acyl homoserine produced by a microorganism can substitute conventional petrochemical products, can solve environmental concerns, including the emission of pollutants and the exhaustion of natural resources, and can be continuously renewable so as not to exhaust natural resources. | 10-02-2014 |
| 20150211034 | Microorganism Producing L-Methionine Precursor and Method of Producing L-Methionine and Organic Acid from the L-Methionine Precursor - The present invention relates to a method for producing L-methionine, comprising: i) culturing an L-methionine precursor-producing microorganism strain in a fermentation solution, so that the L-methionine precursor accumulates in the solution; and ii) mixing a converting enzyme and methylmercaptan or its salts with at least a portion of the solution to convert the accumulated L-methionine precursor into L-methionine, as well as to microorganism strains used in each step. | 07-30-2015 |
Jin-Sook Choi, Suwon-Si KR
| Patent application number | Description | Published |
|---|---|---|
| 20090121296 | Semiconductor device including dummy gate part and method of fabricating the same - In a reliable semiconductor device and a method of fabricating the semiconductor device, a difference in height between upper surfaces of a cell region and a peripheral region (also referred to as a level difference) is minimized by optimizing dummy gate parts. The semiconductor device includes a semiconductor substrate including a cell region and a peripheral region surrounding the cell region, a plurality of dummy active regions surrounded by a device isolating region and formed apart from each other, and a plurality of dummy gate parts formed on the dummy active regions and on the device isolating regions located between the dummy active regions, wherein each of the dummy gate parts covers two or more of the dummy active regions. | 05-14-2009 |
| 20120028435 | SEMICONDUCTOR DEVICE INCLUDING DUMMY GATE PART AND METHOD OF FABRICATING THE SAME - In a reliable semiconductor device and a method of fabricating the semiconductor device, a difference in height between upper surfaces of a cell region and a peripheral region (also referred to as a level difference) is minimized by optimizing dummy gate parts. The semiconductor device includes a semiconductor substrate including a cell region and a peripheral region surrounding the cell region, a plurality of dummy active regions surrounded by a device isolating region and formed apart from each other, and a plurality of dummy gate parts formed on the dummy active regions and on the device isolating regions located between the dummy active regions, wherein each of the dummy gate parts covers two or more of the dummy active regions. | 02-02-2012 |
Jin-Sook Moon, Gyeongsangnam-Do KR
| Patent application number | Description | Published |
|---|---|---|
| 20140128427 | 5-CARBAMOYL-ADAMANTAN-2-YL AMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND PREPARATION PROCESS THEREOF - Provided are a novel derivative of 5-carbamoyl adamantan-2-yl amide or a pharmaceutically acceptable salt thereof, and a pharmaceutical use thereof for inhibiting the activity of 11β-hydroxystreroid dehydrogenase type 1 (11b-HSD1) or for preventing and/or treating various diseases mediated by 11β-hydroxystreroid dehydrogenase type 1. | 05-08-2014 |
Jin-Sook Ryu, Seoul KR
| Patent application number | Description | Published |
|---|---|---|
| 20100113763 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS - The present invention relates to a method for preparation of organofluoro compounds containing radioactive isotope fluorine-18. More particularly, the present invention relates to a method for preparation of organofluoro compound [ | 05-06-2010 |
| 20100261727 | 2-ARYLBENZOTHIOPHENE DERIVATIVES OR PHARCEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARCEUTICAL COMPOSITION FOR THE DIAGNOSIS OR TREATMENT OF DEGENERATIVE BRAIN DISEASE CONTAINING THE SAME AS ACTIVE INGREDIENT - 2-arylbenzothiophene derivatives or pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as an active ingredient. Since the 2-arylbenzothiophene derivatives of Formula 1 have a relatively high binding affinity for β-amyloid, they can be used as diagnostic reagents for diagnosing Alzheimer's disease at an early stage by non-invasive techniques when they are labeled with radioisotopes: | 10-14-2010 |
| 20110112293 | Purification Strategy for Direct Nucleophilic Procedures - The present invention provides novel and advantageous processes for preparing and purifying chemical compounds such as pharmaceuticals. The processes comprise a nucleophilic substitution reaction with a moiety X wherein the leaving group L of a substrate S in the reaction is covalently attached to a purification moiety M. This concept offers a convenient and lime-saving way to purity the desired product S-X from non-reacted precursors S-L-M and by-products L-M. | 05-12-2011 |
| 20120214994 | (3-FLUORO-2-HYDROXY)PROPYL-FUNCTIONALIZED ARYL DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR THE DIAGNOSIS OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASES - The present invention relates to (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or to the pharmaceutically acceptable salt thereof, to a method for preparing same, and to a pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerative brain diseases. The aryl derivatives of the present invention are (3-fluoro-2-hydroxy)propyl-functionalized to increase the polarity thereof, and therefore the drugs containing the aryl derivatives can easily permeate into the cerebrovascular membrane, thus increasing the effectiveness of the drugs. As the aryl derivatives of the present invention strongly bind to β-amyloid, the aryl derivatives, when labeled with radioisotope, can be used as a diagnostic agent for non-invasively diagnosing early Alzheimer's disease. Further, the aryl derivatives of the present invention bind to low molecular β-amyloid peptide conjugates to inhibit the generation of malignant high molecular β-amyloid plaque, and thus can be effectively used as a therapeutic agent for neurodegenerative brain diseases such as Alzheimer's disease. | 08-23-2012 |
| 20140039074 | METHOD FOR RAPID PREPARATION OF SUITABLE [18F]FLUORIDE FOR NUCLEOPHILIC [18F]FLUORINATION - The invention generally relates to the preparation of | 02-06-2014 |
| 20150045548 | METHOD FOR PREPARING FLUORINE-18 ELUENT WITH ADJUSTED PH, AND METHOD FOR LABELLING FLUORINE-18 USING SAME - The present invention relates to a method for labelling fluorine-18, which is a radioisotope, and more specifically, to a method for labelling a [ | 02-12-2015 |
Jin-Sook Ryu, Kangnam-Gu KR
| Patent application number | Description | Published |
|---|---|---|
| 20120238740 | NON-POLAR AND POLAR LEAVING GROUPS - The present invention provides novel and advantageous processes for preparing and purifying pharmaceuticals The processes comprise a nucleophilic reaction wherein a modified leaving group L | 09-20-2012 |